With more than 500,000 deaths each year, malaria (or malaria) remains one of the world’s deadliest diseases. This week, the WHO Africa Office will provide an update on the latest vaccination campaign against the disease. Even though the initiative is primarily aimed at children, a category that accounts for more than three-quarters of malaria deaths worldwide, it is still being criticized for the vaccine’s disappointing performance. Francois Noste, a malaria expert and professor at the University of Oxford, gives an update on the disease. that Figaro. This French doctor and researcher is also the director of the SMRU (Shoklo Malaria Research Unit) in Mae Sot, Thailand, near the border with Burma.
LE FIGARO. – What about the malaria vaccination strategy?
P:r: François NOSTEIN. – The RTS,S vaccine developed by GSK with support from the Bill & Melinda Gates Foundation does not work well. Its effectiveness is 30% against severe cases…
Source: Le Figaro
